Atlas Trials

Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT02791919 · WITHDRAWN

Trial details

NCT number
NCT02791919
Sponsor
National Cancer Institute (NCI)
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
CNS 2aCNS 2bCNS 2cCNS1Recurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid Leukemia
Start date
2017-05-25
Primary completion
2019-05-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.